That's why you could be subject to a serious case of COVID, a new study indicates
New Stanford Research shines a light on how the immune system works in those with severe coronavirus.
TheCoronavirus does not affect everyone in the same way. Some people are infected and find themselves without symptoms, while others finish tragically to become another addition to the growing number of 932,000 VVID-19 death victories. Although we know that some people areConsidered a higher risk for COVID complications Due to the underlying age and medical conditions, one of the biggest questions in the middle of the pandemic was right for which coronavirus affects seemingly healthy people so differently. After all, even if you are not in a higher risk category, you can always experience a serious case of COVID. Now a new study school at Stanford University University shows thatYou might be more subject to a serious case of COVID if your immune cells work more slowly than normal.
The study, which was published on August 11 in the journalScience, observed the immune response of 76 people infected with COVID-19 and 69 healthy people from Hong Kong and Atlanta, Georgia. They found that those with the worst cases of Covid hadimmune cells that were slower and less effective By responding to the SARS-COV-2 virus.
TheNatural immune response in all persons is to quickly feel a virus and launch an immediate attack against it. However, Stanford's new study revealed that the immune cells of those whoexperienced serious cases of COVID were actually enough slow and less immediate in their attack.
"These results reveal howThe immune system goes wrong during coronavirus infections, leading to a serious illness and indicate potential therapeutic targets ","PULENDRAN BALI, PhD, the principal author of the study, said in a declaration.
The study also found that the increase in inflammation plays a role inDelete the immune response, also. The researchers found higher levels of bacterial debris in the blood of severe covidant patients and that debris are apparently in the bloodstream of these patients, activating inflammation.
Researchers have also found higher levels of molecules that promote inflammation in the blood of GVID-19 serious patients. Three of these molecules-in-rage, TNFSF14 and OSM-have generally been responsible for pulmonary inflammation in other diseases, but this study is the first to show them in COVID-19 infections.
RELATED:For more information up to date, sign up for our daily newsletter.
"One of the great mysteries of CIVID-19 infections has been that some people develop a severe disease, while others seem to recover quickly," said Plandran in a statement. "Now we have ideas in the reason why it happens." And for more information on the different cases of coronavirus, checkThat's why some people have no symptoms of COVID, a new study shows.
